| Tag | Content |
|---|
EnhancerAtlas ID | HS060-02329 |
Organism | Homo sapiens |
Tissue/cell | GM12891 |
Coordinate | chr1:161580880-161582880 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161582764-161582782 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161582760-161582778 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161582351-161582361 | GGGGCGGGGC | - | 6.02 | | TFAP2A | MA0003.3 | chr1:161581075-161581086 | CGCCTCAGGCT | + | 6.14 | | ZNF263 | MA0528.1 | chr1:161582760-161582781 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 | | ZNF263 | MA0528.1 | chr1:161582205-161582226 | TGAGGAGTGCGGGGGGGAAGA | + | 6.2 |
|
| | Number of super-enhancer constituents: 14 | ID | Coordinate | Tissue/cell |
| SE_07357 | chr1:161580788-161584698 | Brain_Hippocampus_Middle_150 | | SE_09867 | chr1:161579384-161583530 | CD14 | | SE_12235 | chr1:161581303-161583400 | CD3 | | SE_12654 | chr1:161581792-161582273 | CD34_adult | | SE_12771 | chr1:161581912-161582301 | CD34_fetal | | SE_12771 | chr1:161582578-161582932 | CD34_fetal | | SE_13494 | chr1:161579645-161584358 | CD34_Primary_RO01536 | | SE_15335 | chr1:161579226-161584686 | CD4_Memory_Primary_7pool | | SE_16693 | chr1:161581295-161583416 | CD4_Naive_Primary_8pool | | SE_20036 | chr1:161580924-161584169 | CD56 | | SE_20740 | chr1:161577990-161584457 | CD8_Memory_7pool | | SE_22436 | chr1:161580812-161584433 | CD8_primiary | | SE_39938 | chr1:161580902-161584380 | K562 | | SE_53727 | chr1:161580858-161583334 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 4 | Chromosome | Start | End |
| chr1 | 161582451 | 161582780 | | chr1 | 161581253 | 161581372 | | chr1 | 161582212 | 161582506 | | chr1 | 161581400 | 161582169 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161611 | chr1 | 161580791 | 161583390 |
|
Enhancer Sequence | CCTTTCTACT TCCCCTAATG TTAAAACCTT ACATAACCAT GTTATATTTA TCAAACCTAA 60
GAAATTGGCA TTGGTATAAC ATTAATGACT TTTTTTTTTT TTTTTGGACA CAGGGTCTCA 120
CTCTGTACCC CAGCCTGGAG TGCAGTGGCA CGATCTCGGC TCACTGCAAC CTCTGCCCCC 180
TGGGCTCAAG AGATTCGCCT CAGGCTCCCG GAGTAGCTGG GACTACAGGC GCGAACCCCG 240
GGTACTTGGG AGGCTGAGGC ACGAGAACCG CGTGGACCGG GAAGACGGAG GCTGCAGTGA 300
GCCAAGATCG CGCCACAGTA CTCCAGCCTG GGGTACAGAG TGAGAACCTG TCTCAAAAAA 360
AAAAAAAAAA AAGCTGGGGA GCGGGGCAAG GCGGTGGAGA ATCTGATCCT TACCAAAGTT 420
TGACACTACT GCGTTAGCGT TAAAAAAAAA ACCCAGCTAA GACTGTAGAG CAAATTAAAG 480
GATCCTGTGT TGAGGGCGTT CTCTTGTTTA GTCAAAGGAG ATGGTATCTG CCTGCCTTAG 540
TGTGCTTGAC GCACAGAAAG GGCTCAACAC ATTGTTGTTG AATAAAAGAA TGGATAAATT 600
GACACTGGGA AGTTGGAGTC CAAAGTTAAA CTTAGTCTCA ACTGCTCCCT GTTTTCATAG 660
ACCAGACTCC AGCCTACAAT ACAGGAAAAA TAGATTTAGT TCTATATGTG CAGAGAAGCA 720
CAAATAATTT TCGTAAATGT AGATACCCAG GATAAAACGC AGTGTTGACC GATCGAAAAG 780
TCTTTCTCTA AGAATTCAAA CATAATTGCT GGTTGGTTCA AATCAGGAGG AAAAGTAAGG 840
ATGGAAAACA TACGTTGTCA AAAGTGGGAT TCGAACCCAC GCCTCCAGCG GAGGGTGCGA 900
TTTGAACGCA GCGCCTTAAG ACTGCTCGGC CATCCTGACA CACGTTTTGC TAAACTTCCT 960
AATTTCTCCT AATTTTATCA TATACTGATG GTGCACGCTA TCAGGTCACA TTAATGTGTC 1020
TATTTACTGT TTCAAATAAA ATTGTAACTC TCTCTAGACC TTGTCGCAAA GCGGGAAAAA 1080
TGAAACAGCC TCCGACAGCT CTTTCCTCTT TCCTCACTAC CCAAACTAAA CCTTAAGGCT 1140
CCATTTTCCC TGGCGACTCT TCGAGCGCCC CTCTGCTTCT GTAGAGGGGT CGAGCCATGT 1200
CAAGGTAGAC CCTGTGTCGG CCCGTCTCCC TCGGATCCTC CGCACCAATC ACTGTTGCTG 1260
AATCCGACAC CCGGCGGATC CAGTGCGGAG TCTCGAACAG CTGCGGAGCT GGGAGCTACG 1320
GGACATGAGG AGTGCGGGGG GGAAGAGAAG ACGGCGGAGG AAAATCCCCC GGCGGTGCTC 1380
AACTGCGGCT TTCTCTCTCG GCTGTGAGCC GGCTCCGCCC TCCGGCTTCC AGAGCAAGTG 1440
GCTTCTGCGT TCACCGCCCC CCGCCGTTTG TGGGGCGGGG CCGATTCATA AGAATCGGTT 1500
CTCACCAATG GAGGGCTTAG CATGTTTAAC CTCAGGATCA TAAACAAAAG ACACTGCTAG 1560
AACGGTCGGG AAAGTCATAC GCTTTGCTTA TCTTATATAT AGATTTCTAA AATTCCAAAC 1620
CGGGGACGCG TTGGTGGTGT AGTGGTGAGC ACAGCTGCCT TTCAAGCAGT TAACGCGGGT 1680
TCGATTCCCG GGTAACGAAA CGTTTTTGTC TTTCCTTCTA CGAAAAACTT TTCTGAGCCG 1740
GAGCCTCCAG CGCGCTGTGT ATTCGTTTTA CGCCTCAACG AAACTGCAGC AATACCTCAC 1800
TTTCCGTACT CGCTTCCTGT CTTTCCCCTG GCCTCTTTCT AAACCCAGGC TTTTTTTGAA 1860
GGGATTAAAT TCTGATGGTT CTTTCCTCCC TTCCTTCCTT TGTAAACTTC CAACTCTTGA 1920
GGAATCTTTG GGATCATTTC AATCCTGGGA TGAGTCTTAG CTTCAGAAAG GGGCTCTTGT 1980
GTCTTCACTT GCGAGGTTCA 2000
|
